Acute dynamic exercise mobilizes CD34+ hematopoietic stem cells (HSCs) to the bloodstream, potentially serving as an economical adjuvant to boost the collection of HSCs from stem cell transplant donors. The mechanisms responsible for HSC mobilization with exercise are unknown but are likely due to hemodynamic perturbations, endogenous granulocyte-colony stimulating factor (G-CSF), and/or b 2 -adrenergic receptor (b 2 -AR) signaling. We characterized the temporal response of HSC mobilization and plasma G-CSF following exercise, and determined the impact of in vivo b-AR blockade on the exercise-induced mobilization of HSCs. Healthy runners (n = 15) completed, in balanced order, two single bouts of steady state treadmill running exercise at moderate (lasting 90-min) or vigorous (lasting 30-min) intensity. A separate cohort of healthy cyclists (n = 12) completed three 30-min cycling ergometer trials at vigorous intensity after ingesting: (i) 10 mg bisoprolol (b 1 -AR antagonist); (ii) 80 mg nadolol (b 1 + b 2 -AR antagonist); or (iii) placebo, in balanced order with a double-blind design. Blood samples collected before, during (runners only), immediately after, and at several points during exercise recovery were used to determine circulating G-CSF levels (runners only) and enumerate CD34+ HSCs by flow cytometry (runners and cyclists). Steady state vigorous but not moderate intensity exercise mobilized HSCs, increasing the total blood CD34+ count by $4.15 ± 1.62 Dcells/ml (+202 ± 92%) compared to resting conditions. Plasma G-CSF increased in response to moderate but not vigorous exercise. Relative to placebo, nadolol and bisoprolol lowered exercising heart rate and blood pressure to comparable levels. The number of CD34+ HSCs increased with exercise after the placebo and bisoprolol trials, but not the nadolol trial, suggesting b 2 -AR signaling mediated the mobilization of CD34+ cells [Placebo: 2.10 ± 1.16 (207 ± 69.2%), Bisoprolol 1.66 ± 0.79 (+163 ± 29%), Nadolol: 0.68 ± 0.54 (+143 ± 36%) Dcells/mL]. We conclude that the mobilization of CD34+ HSCs with exercise is not dependent on circulating G-CSF and is likely due to the combined actions of b 2 -AR signaling and hemodynamic shear stress.
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Introduction
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the preferred treatment for many patients with blood cancers, genetic disorders and primary immune deficiency disorders (Copelan, 2006; Holtick et al., 2014; Passweg et al., 2012) . Hematopoietic stem cells (HSCs) are preferentially collected from the peripheral blood of healthy donors following a period of granulocyte-colony stimulating factor (G-CSF) therapy designed to proliferate and mobilize CD34+ HSCs from the bone marrow (Barrett and Treleaven, 1998; England et al., 2016) . Donors typically undergo apheresis when the blood CD34+ count exceeds 10 cells/lL as this increases the likelihood of collecting 4-4.5 Â 10
